ANKRD12 inhibitors refer to a specific class of chemical compounds that target the ANKRD12 protein, which belongs to the ankyrin repeat domain family. ANKRD12 is characterized by the presence of multiple ankyrin repeat motifs, which are known for mediating protein-protein interactions. These structural motifs allow ANKRD12 to participate in various cellular processes by facilitating the assembly of multi-protein complexes. Inhibitors of ANKRD12 are designed to disrupt these protein-protein interactions by binding to the ankyrin repeat domains or interacting sites, ultimately destabilizing the complexes formed by ANKRD12. By interfering with the structural role of ANKRD12 in such complexes, these inhibitors can influence critical cellular pathways that depend on its function.
Chemically, ANKRD12 inhibitors display a broad range of structural diversity, including small molecules, peptides, and larger synthetic constructs. The design of these inhibitors often centers around the ability to interfere with key hydrophobic or electrostatic interactions within the ankyrin repeat domains. In some cases, inhibitors may mimic the natural binding partners of ANKRD12, competing for binding sites and preventing the protein from interacting with its functional partners. Alternatively, some inhibitors induce conformational changes that alter the stability of the ankyrin repeats, thus impeding the proper assembly of complexes involving ANKRD12. This class of inhibitors offers valuable tools for studying the specific molecular roles of ANKRD12 in cellular contexts, providing insights into the structural dynamics and interactions that are critical for the protein's function in a range of biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to altered chromatin structure and potentially downregulating ANKRD12 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine incorporates into DNA, inhibiting DNA methyltransferases and could result in the repression of ANKRD12 gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, an HDAC inhibitor, changes the chromatin state, which could suppress transcription of the ANKRD12 gene. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 prevents DNA methylation by inhibiting DNA methyltransferases, potentially decreasing ANKRD12 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, possibly blocking transcription factors from inducing ANKRD12 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, potentially inhibiting transcription initiation and elongation of the ANKRD12 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Sirolimus binds to mTOR, which may lead to downstream effects that decrease ANKRD12 transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can alter DNA and RNA synthesis, which may result in reduced expression of ANKRD12. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is known to modulate gene expression and could potentially inhibit ANKRD12 transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, leading to DNA damage responses that could suppress ANKRD12 gene expression. | ||||||